Market Overview

Cramer Weighs In On Biogen, Caterpillar And More

Cramer Weighs In On Biogen, Caterpillar And More

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Biogen Inc (NASDAQ: BIIB). He is concerned about the stock because a Baird analyst expressed his skepticism about Biogen's Alzheimer's drug.

Amgen, Inc. (NASDAQ: AMGN) is a much better company than it was six months ago, said Cramer. If it trades back to $210, he would be willing to buy it.

Cramer would sell some Caterpillar Inc. (NYSE: CAT) and buy it back at a lower price. He thinks the company isn't going to have a good quarter and he is worried about trade tariffs.

See Also: Can Tesla's Stock Continue Revving After 50% Rally?

ABIOMED, Inc. (NASDAQ: ABMD) has been de-risked and Cramer would buy the stock.

Northrop Grumman Corporation (NYSE: NOC) is cheap, said Cramer. He would start buying it within the next couple of days. He likes Lockheed Martin Corporation (NYSE: LMT) more.

Cramer would not buy Tegna (NYSE: TGNA). He thinks it's going to be possible to buy it later at a lower price.


Related Articles (BIIB + CAT)

View Comments and Join the Discussion!

Posted-In: CNBC Jim Cramer mad money Lightning RoundMedia